Genevoyager (Wuhan) Co., Ltd.
One-stop CRO/CDMO for viral vectors, proteins, and vaccines with proprietary AAV manufacturing platform.
Listed on cro.directory
Leading CRO/CDMO provider specializing in viral vectors, proteins, and vaccines with proprietary AAV manufacturing technology and cGMP-grade facilities operational since October 2023. Headquartered in Wuhan, China.
Phases
Services
Modalities
Technical specifications & accreditations
Accreditations
About this organization
Genevoyager is a one-stop CRO/CDMO services provider focused on viral vectors, proteins, and therapeutic vaccines. The company operates a proprietary technology platform for large-scale AAV manufacturing and maintains cGMP-grade production facilities.
Capabilities & Infrastructure:
- Proprietary insect baculovirus system (One-Bac 4.0) for AAV expression with single-batch production capacity up to 1E+18 vg
- cGMP facility in Jiangxia District, Wuhan: 68,000 ft² with 5 viral vector production lines and 1 fill & finish line (operational since October 2023)
- Team of 300 professionals with expertise in viral vector R&D, preclinical efficacy evaluation, CMC development, QA/QC, and GMP production
Subsidiary: BrainVTA (Wuhan) Co., Ltd., established 2014, operates as a CRO delivering viral reagents and customized technical services, with established presence in the academic market.
Certifications
| Authority | Identifier | Source |
|---|---|---|
| China | High-tech Enterprise (高新技术企业) | View |
Locations
Headquarters & cGMP Facility
Wuhan · Jiangxia District · China
Submit a verified review for this organization.
Markdown mirror: /companies/genevoyager-2.md